AMRUTANJAN

Amrutanjan Health Care Limited

Pain-management and personal care products including pain balms and sanitary napkins

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

amrutanjan.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹513.80
Market cap
1,485 Cr
Stock P/E
27.5
P/B
4.01
Dividend yield
0.9%
ROE (FY26)
15.6%
ROCE (FY26)
21.1%
Operating margin (FY26)
13.8%
OCF / EBITDA (FY26)
47.5%
OCF / EBITDA (3Y)
62.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Amrutanjan Health Care is a consumer healthcare company that sells over-the-counter pain balms and roll-ons under the Amrutanjan brand, along with Comfy sanitary napkins, Relief congestion products and Electro+ hydration drinks.

Company snapshot

83rdBy market cap

Ranked among 119 companies in Pharmaceuticals.

Segment mix

Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.

Largest segment: 71.6% of revenue

SegmentRevenue shareRevenuePBTAssets
Beverages
3.6%
4 Cr-0.28 Cr24 Cr
OTC Products
71.6%
88 Cr24 Cr68 Cr
Others
0.4%
0.48 Cr-0.16 Cr1 Cr
Women Hygiene
24.4%
30 Cr-0.47 Cr37 Cr

What we see

Positives
  • ✓Interest coverage of 355.7x — earnings comfortably cover interest obligations.

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales99 Cr117 Cr127 Cr84 Cr110 Cr123 Cr135 Cr94 Cr118 Cr141 Cr150 Cr103 Cr
Operating expenses (approx.)92 Cr95 Cr111 Cr80 Cr96 Cr99 Cr118 Cr86 Cr101 Cr116 Cr124 Cr97 Cr
EBITDA7 Cr22 Cr16 Cr4 Cr14 Cr23 Cr18 Cr8 Cr17 Cr25 Cr26 Cr6 Cr
OPM %6.9%18.4%12.3%4.2%12.4%19.0%13.1%9.0%14.0%17.8%17.1%6.1%
Other income4 Cr4 Cr6 Cr4 Cr4 Cr4 Cr5 Cr4 Cr4 Cr4 Cr5 Cr4 Cr
Interest0.03 Cr0.05 Cr0.05 Cr0.06 Cr0.06 Cr0.06 Cr0.04 Cr0.05 Cr0.05 Cr0.05 Cr0.05 Cr0.04 Cr
Depreciation2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax9 Cr24 Cr20 Cr6 Cr16 Cr26 Cr21 Cr11 Cr19 Cr26 Cr21 Cr6 Cr
Tax %25.6%26.4%30.3%27.3%26.0%25.9%27.2%26.4%27.3%26.2%23.0%28.1%
Net profit7 Cr17 Cr14 Cr5 Cr12 Cr19 Cr15 Cr8 Cr14 Cr19 Cr16 Cr4 Cr
EPS (₹)₹2.36₹6.05₹4.72₹1.60₹4.08₹6.66₹5.25₹2.87₹4.83₹6.73₹5.60₹1.51

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales217 Cr225 Cr253 Cr261 Cr333 Cr406 Cr380 Cr421 Cr452 Cr503 CrSign in free for the trailing twelve months
Operating expenses (approx.)187 Cr196 Cr222 Cr231 Cr258 Cr326 Cr335 Cr370 Cr394 Cr427 CrSign in free for the trailing twelve months
EBITDA30 Cr28 Cr31 Cr31 Cr75 Cr79 Cr44 Cr51 Cr58 Cr76 CrSign in free for the trailing twelve months
OPM %13.8%12.6%12.4%11.7%22.5%19.6%11.7%12.2%12.9%15.1%Sign in free for the trailing twelve months
Other income7 Cr6 Cr7 Cr8 Cr11 Cr15 Cr15 Cr17 Cr18 Cr18 CrSign in free for the trailing twelve months
Interest0.13 Cr0.13 Cr0.08 Cr0.22 Cr0.50 Cr0.48 Cr0.08 Cr0.16 Cr0.22 Cr0.20 CrSign in free for the trailing twelve months
Depreciation2 Cr3 Cr3 Cr4 Cr4 Cr4 Cr5 Cr6 Cr7 Cr6 CrSign in free for the trailing twelve months
Profit before tax35 Cr33 Cr35 Cr34 Cr82 Cr91 Cr54 Cr62 Cr69 Cr78 CrSign in free for the trailing twelve months
Tax %34.2%39.2%29.3%27.2%25.3%25.8%25.7%27.4%26.5%25.6%Sign in free for the trailing twelve months
Net profit22 Cr20 Cr25 Cr25 Cr61 Cr67 Cr40 Cr45 Cr51 Cr58 CrSign in free for the trailing twelve months
EPS (₹)₹7.46₹6.83₹8.38₹8.58₹20.94₹23.05₹13.65₹15.56₹17.58₹20.03Sign in free for the trailing twelve months
Dividend payout %————7.6%20.0%33.8%29.8%26.1%22.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Reserves113 Cr126 Cr143 Cr157 Cr213 Cr262 Cr288 Cr286 Cr324 Cr367 Cr
Borrowings2 Cr—————————
Other liabilities34 Cr37 Cr42 Cr46 Cr59 Cr85 Cr71 Cr78 Cr95 Cr139 Cr
Total liabilities152 Cr166 Cr188 Cr205 Cr274 Cr350 Cr362 Cr367 Cr421 Cr509 Cr
Fixed assets (net)27 Cr27 Cr25 Cr26 Cr23 Cr27 Cr46 Cr47 Cr48 Cr50 Cr
CWIP0.68 Cr———0.41 Cr16 Cr1 Cr2 Cr16 Cr105 Cr
Investments10 Cr8 Cr18 Cr18 Cr18 Cr13 Cr5 Cr0.0005 Cr0 Cr3 Cr
Inventories10 Cr10 Cr15 Cr24 Cr17 Cr26 Cr29 Cr29 Cr27 Cr37 Cr
Trade receivables29 Cr28 Cr33 Cr26 Cr18 Cr38 Cr33 Cr48 Cr56 Cr61 Cr
Cash & bank25 Cr29 Cr15 Cr7 Cr3 Cr2 Cr5 Cr4 Cr10 Cr11 Cr
Other assets51 Cr64 Cr83 Cr104 Cr195 Cr227 Cr243 Cr237 Cr264 Cr241 Cr
Total assets152 Cr166 Cr188 Cr205 Cr274 Cr350 Cr362 Cr367 Cr421 Cr509 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity8 Cr6 Cr21 Cr18 Cr17 Cr53 Cr19 Cr28 Cr51 Cr36 Cr
Cash from investing-0.29 Cr8 Cr-11 Cr-14 Cr-15 Cr-36 Cr-2 Cr19 Cr-31 Cr-21 Cr
Cash from financing-5 Cr-9 Cr-7 Cr-12 Cr-6 Cr-18 Cr-14 Cr-48 Cr-13 Cr-14 Cr
Net cash flow3 Cr4 Cr3 Cr-7 Cr-4 Cr-0.72 Cr3 Cr-1 Cr6 Cr1 Cr
Free cash flow (OCF − Capex)4 Cr2 Cr19 Cr16 Cr15 Cr30 Cr10 Cr21 Cr15 Cr-19 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %29.8%25.7%23.9%21.7%38.2%34.3%18.5%21.5%21.2%21.1%
ROE %18.8%15.5%16.8%15.7%28.4%25.3%13.7%15.6%15.6%15.6%
Debtor days48454737193432414544
Inventory days52525998737810010299128
Days payable130132120130170181164197250242
Cash conversion cycle-30-35-145-78-69-33-54-106-71
OCF / EBITDA %27.5%19.4%67.7%59.2%22.7%66.9%43.3%54.5%87.5%47.5%
OCF / EBITDA % (3 years)——38.9%49.6%41.2%47.7%45.0%57.3%63.7%62.0%
Debt / equity0.02—————————
Current ratio3.353.843.873.224.283.554.124.233.442.31
Net debt / EBITDA-0.76-1.03-0.47-0.24-0.04-0.03-0.11-0.07-0.17-0.15